Tag: Ascensia Diabetes Care

BASEL, Switzerland – Ascensia Diabetes Care has successfully completed the initial European launch of the next-generation Eversense E3 CGM System. The benefits of this fully-implantable, long-term CGM system are now available to people with diabetes in all launch markets across Europe in Germany, Switzerland, Poland, Italy, Spain, Norway, Sweden, the Netherlands and Andorra. “We are proud to have successfully brought the Eversense E3 to Europe, where we believe it can make a big difference...

BASEL, Switzerland – Ascensia Diabetes Care has relaunched its “This is Diabetes” art and photo competition in support of World Diabetes Day 2022. The competition aims to highlight the importance of diabetes care and education, amplifying the International Diabetes Federations’ official theme of Access to Diabetes Care for 2021-2023, and its focus this year on Education to Protect Tomorrow. Ascensia’s global competition is seeking original art or photography that illustrates...

PARSIPPANY, N.J. – Diabetes management is taking a “big leap forward” with the Eversense E3, an implantable continuous glucose monitor, which was recently approved for use up to six months, says Elaine Anderson, head of the Eversense CGM business unit at Ascensia Diabetes Care.  “This is double the lifetime of what people had – you replace it twice (a year),” she said. “It’s not sacrificing accuracy, it’s easy on, easy off so you can take...

BASEL, Switzerland – People who use Ascensia Diabetes Care’s connected CONTOUR BGM systems (BGMS) and CONTOUR DIABETES App (CDA) for at least six months can see a reduced frequency of hypoglycemic and hyperglycemic blood glucose readings, according to a new study from the company. “We’re pleased to see results from the study showcasing that our CDA system is helping people with diabetes to manage their condition,” said Frank Held, head of BGM marketing and strategy....

PARSIPPANY, N.J. – Ascensia Diabetes Care has launched the next-generation Eversense E3 Continuous Glucose Monitoring System for patients in the U.S., alongside the new Eversense PASS savings program. Eversense E3, which is developed be Senseonics Holdings, was approved for use up to six months by the U.S. Food and Drug Administration earlier this year, making it the longest lasting CGM sensor available in the country. “We are thrilled to offer Eversense E3 to people with diabetes in...

As the diabetes market observes the 100th anniversary of insulin therapy, manufacturers are optimistic about the growth of medical technology in the category. Specifically, the evolution of continuous glucose meters has charted a path forward for the industry to follow, they say.  Elaine Anderson, head of the Eversense CGM business unit at Parsippany, N.J.-based Ascensia Diabetes Care, calls CGM the “first step change” in diabetes treatment since the “transformative discovery”...

SAN DIEGO – 9am.health, a virtual diabetes clinic, now offers the Contour Next One blood glucose meter and Contour Next test strips to its patients with Type 2 diabetes and prediabetes to complement its care offering. “We are excited to team up with 9am.health to bring the benefits of our products to more people with diabetes,” said Frank Held, head of BGM marketing and strategy at Ascensia Diabetes Care. “Our remarkably accurate Contour Next One glucose meter is a great addition...

PARSIPPANY, N.J. – Ascensia Diabetes Care has launched the Eversense NOW Remote Monitoring App for the Android Operating System in Europe. The Eversense NOW Remote Monitoring App allows real-time glucose data and alerts from Eversense users to be remotely shared with friends and family. The app allows up to five people to remotely receive updated readings approximately every five minutes, with the ability to easily view recent trends and alerts.  “The value of remote monitoring in...

BASEL, Switzerland – Ascensia Diabetes Care is supporting the Spare a Rose campaign, which encourages people to donate the money they would otherwise spend on a rose on Valentine’s Day to charity, for the fifth consecutive year. Ascensia is encouraging its 1,500 employees to donate to Spare a Rose and has committed to matching their donations up to one rose, or $5, per employee, plus an initial $5,000 donation. “The Spare a Rose campaign was created by the diabetes community, for...

BASEL, Switzerland – Ascensia Diabetes Care has launched a Patient Assistance Program to reduce out-of-pocket costs for its Eversense Continuous Glucose Monitoring System. “Our fundamental goal at Ascensia is to simplify and improve the lives of people living with diabetes through technologies that facilitate better outcomes and reduce the burden of managing the condition,” said Mary Puncochar, head of Ascensia’s Region US. “We therefore want to be able to offer Eversense...